| FAGRON N.V. PORT. |
| Belgien |
| Gesundheit |
| BE0003874915 / A0M103 |
| 4A5 (Frankfurt) |
| FRA:4A5, ETR:4A5, 4A5:GR |
| - |
| https://fagron.com/ |
|
Fagron NV is a publicly traded multinational company governed by Belgian law, specializing in pharmaceutical compounding to enable personalized medicine for hospitals, pharmacies, clinics, and patients worldwide. Headquartered in Rotterdam, Netherlan..
>Volltext.. |
| 1663.86 Mio. EUR |
| 2172.44 Mio. EUR |
| 1043.46 Mio. EUR |
| 200.87 Mio. EUR |
| 93.07 Mio. EUR |
| 1.27 EUR |
| 645.79 Mio. EUR |
| 133 Mio. EUR |
| 138.82 Mio. EUR |
| 0.47 |
| 11.95% |
| 7.06% |
| 0.4 EUR |
| 1.24% |
| 1.24% |
| 18.05.26 - 0.4€ 19.05.25 - 0.35€ >weitere anzeigen... |
| - |
| FAGRON |
| 08.10.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|